The Crucial Role of Electrolytes in Diabetic Patients: article Review

Authors

  • Noor Thair Tahir National Diabetes Center, Mustansiriyah University, Baghdad, Iraq
  • Sahar Abdul Wahab ALShaban Department of Chemistry and Biochemistry ,College of Medicine, Mustansiriyah University, Baghdad, Iraq
  • Tawfeeq F. R. Al-Auqbi National Diabetes Center, Mustansiriyah University, Baghdad, Iraq

DOI:

https://doi.org/10.32947/ajps.v25i5.1298

Keywords:

diabetes mellitus, electrolite imbalance, magnesium, phosporus, potasium, sodium

Abstract

Patients with diabetes often experience a variety of electrolyte imbalances. These patients have significant disorders deficiencies in phosphate, magnesium, and potassium Both hypo- and hyper-natremia are associated with diabetes mellitus, which is indicative of the coexistence of processes related to hyperglycemia that tend to alter blood sodium in opposite ways.

Hyper tonicity, insulin insufficiency, potassium-sparing medications, and impaired renal function are other factors that contribute to the development of hyperkalemia. The electrolyte abnormalities that occur in diabetes mellitus are summarized in this article along with the fundamental mechanism. These strategiesare designed to realization should open the door to pathophysiology directed treatment, which will help prevent the various negative consequences linked to electrolyte imbalances and their management. In people with diabetes, electrolyte imbalances are frequent and may be linked to higher rates of morbidity and death. Those with decompensated diabetes mellitus, the elderly, and those with renal impairment are more likely to have these disruptions. Doctors prescribe complex treatment regimens that work to regulate electrolyte imbalance in diabetics in order to control blood sugar levels. It is best to understand the physiological mechanism of patients suffering from electrolyte imbalance, which plays an important role in controlling sugar levels in diabetics.

 

References

Ahmed HS, Thair NT. Chemerin as a New Marker in Iraqi Newly Diagnosed Type 2 Diabetes Mellitus. Al Mustansiriyah Journal of Pharmaceutical Sciences. 2015.1;15(1):6-13..

2- Palmer B, Clegg D. Electrolyte and acid-base disturbances in patients with diabetes mellitus. N Engl J Med. 2015;373(6):548–559.

3- Tahir, Noor Thair; Ahmed, Hind Shakir1; Mahmmod, Omar Khairi2. Correlation between High Sensitivity C-Reactive Protein and Incident Type 2 Diabetes among Newly Diagnosed Renal Impairment Patients. Iraqi Journal of Community Medicine 33(1):p 10-14, Jan–Jun 2020. *

4- Fadhil A H., Al-Rubaey M G. Blood Lead Level among Chronic Kidney Diseases Patients Attended Medical City Hospital in Baghdad 2022. Iraqi Journal of Community Medicine,2024; 37(1), 6-10.

5- Ashraf R, Naikoo N, Bashir H, Farooq I. Electrolyte Imbalance in the Patients Admitted To the Emergency Department of the Tertiary Care Hospital of Smhs Hospital, Srinagar. International Journal of Current Research. 2018;10(4):67854–67857

6- Ibrahim SL., Alzubaidi, Z F., & Al-Maamory F A. (2022). Electrolyte disturbances in a sample of hospitalized patients from Iraq. Journal of Medicine and Life, 15(9), 1129.

7- Gallwitz B. Clinical Use of DPP-4 Inhibitors. Front Endocrinol (Lausanne) 2019; 10: 389.

8- Noda Y, Sasaki S. Updates and Perspectives on Aquaporin-2 and Water Balance Disorders. Int J Mol Sci 2021; 22: 12950.

9- Girndt M. Störungen des Elektrolytstoffwechsels [Electrolyte disorders]. Internist (Berl). 2011. ;52(8):963-74.

10- Ferrannini E, DeFronzo RA. Impact of glucose-lowering drugs on cardiovascular disease in type 2 diabetes. Eur Heart J 2015; 36: 2288-2296.

11- Al-Bayati AH, Al-Khateeb SM. The association between glycaemic level and lipid profile with Albuminuria in Iraqi type 2 diabetes patients—A cross sectional study. JPMA. The Journal of the Pakistan Medical Association; 2021; 71(12), S57-S62.

12- Funk GC, Lindner G, Druml W, Metnitz B, Schwarz C, Bauer P, Metnitz PG. Incidence and prognosis of dysnatremias present on ICU admission. Intensive care medicine. 2010; 36:304-311.

13- Liamis, G., Liberopoulos, E., Barkas, F., & Elisaf, M. (2014). Diabetes mellitus and electrolyte disorders. World Journal of Clinical Cases: WJCC, 2(10), 488.

14- ‏Królicka A, Letachowicz K, Adamik B, Doroszko A, Kaliszewski K, Kiliś-Pstrusińska K, Kujawa K, Matera-Witkiewicz A, Madziarski M, Pomorski M, Protasiewicz M. Dysnatremia in COVID-19 Patients—An Analysis of the COLOS Study. Journal of Clinical Medicine. 2023 10;12(8):2802.

15- Al-Garawi ZS, Taha AA, Abd AN, Tahir NT. Immobilization of urease onto nanochitosan enhanced the enzyme efficiency: biophysical studies and in vitro clinical application on nephropathy diabetic iraqi patients. Journal of Nanotechnology. 2022;2022(1):8288585.

16- Miyauchi T, Nishiwaki H, Mizukami A, Yazawa M. Hyponatremia and mortality in patients undergoing maintenance hemodialysis: Systematic review and meta‐analysis. InSeminars in Dialysis 2023 : 36(4) 303-315.

17- Mezzini G, Marasco S, Bertuccio A, Savioli G, Piccolella F, Racca F, Barbanera A, Vitali M. Hyponatremia Related to Neurocritical Care: Focus on Diagnosis and Therapy: A Systematic Review. Reviews on Recent Clinical Trials. 2023:18(1):19-27.

18- Thongprayoon C, Cheungpasitporn W, Yap JQ, Qian Q. Increased mortality risk associated with serum sodium variations and borderline hypo-and hypernatremia in hospitalized adults. Nephrology Dialysis Transplantation. 2020 :35(10):1746-52.

19- Asmara H, Abd Kadir SZ, Wan-Arfah N, Meramat A. Effects of Hypernatremia on Blood Pressure and Cardiovascular Disease: A Systematic Review and Meta-Analysis. Asian Journal of Medicine and Biomedicine. 2023: 24:77-85.

20- Ing, Todd S., Kavitha Ganta, Gautam Bhave, Susie Q. Lew, Emmanuel I. Agaba, Christos Argyropoulos, and Antonios H. Tzamaloukas. "The corrected serum sodium concentration in hyperglycemic crises: computation and clinical applications." Frontiers in Medicine 7 (2020): 477.

21- Busl KM, Rabinstein AA. Prevention and correction of dysnatremia after aneurysmal subarachnoid hemorrhage. Neurocritical care. 2023 ;39(1):70-80.

22- Lee T, Flythe JE, Allon M. Dialysis care around the world: a global perspectives series. Kidney360. 2021; 2(4): 604-607.

23- Mohan S, Gu S, Parikh A, Radhakrishnan J. Prevalence of hyponatremia and association with mortality: results from NHANES. Am J Med. 2013; 126(12): 1127-1137.

24- Hegazi MO, Mashankar A. Central pontine myelinolysis in the hyperosmolar hyperglycaemic state. Med Princ Pract. 2013;22:96–99

25- . Simon, Leslie V., Muhammad F. Hashmi, Mitchell W. Farrell, and Rojeena Chapagain. "Hyperkalemia (nursing)." (2021).

26- McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, Burri H, Butler J, Čelutkienė J, Chioncel O, Cleland JGF, Coats AJS, Crespo-Leiro MG, Farmakis D, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CSP, Lyon AR, McMurray JJV, Mebazaa A, Mindham R, Muneretto C, Francesco Piepoli M, Price S, Rosano GMC, Ruschitzka F, Kathrine Skibelund A; ESC Scientific Document Group. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021 Sep 21;42(36):3599-3726. doi: 10.1093/eurheartj/ehab368. Erratum in: Eur Heart J. 2021.22(48):4901.

27- Coregliano-Ring L, Goia-Nishide K, Rangel ÉB. Hypokalemia in Diabetes Mellitus Setting. Medicina (Kaunas). 2022 Mar 16;58(3):431. doi: 10.3390/medicina58030431. PMID: 35334607; PMCID: PMC8954285.

28- Raebel MA. Hyperkalemia associated with use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers. Cardiovasc Ther . 2012.30(3):156–166.

29- Linder KE, Krawczynski MA, Laskey D. Sodium zirconium cyclosilicate (ZS-9): a novel agent for the treatment of hyperkalemia. Pharmacotherapy .2016:36(8):923–933.

30- Colbert GB, Patel D, Lerma EV Patiromer for the treatment of hyperkalemia. Expert Rev Clin Pharmacol. 2020. 13(6):563–570.

31- Kim K, Fagerström J, Chen G, Lagunova Z, Furuland H, McEwan P . Cost effectiveness of sodium zirconium cyclosilicate for the treatment of hyperkalaemia in patients with CKD in Norway and Sweden. BMC Nephrol. 2022. 23(1):1–11.

32- Montagnani A, Frasson S, Gussoni G, Manfellotto D. Optimization of RAASi therapy with new potassium binders for patients with heart failure and hyperkalemia: rapid review and meta-analysis. J Clin Med.2021

33- Zaid MH, Al-Fartusie FS, Pazhang Y, Kader S. Evaluation of lipid profile, liver function enzymes, and trace elements in Iraqi diabetic nephropathy patients. BioMetals. 2024 . 23:1-0.

34- Al_Jaree AS, Mahdi RQ, Hassan JA, Tohma FK. The Interplay of Thyroid Hormones, Body Mass Index, and Kidney Function in Wasit City: Implications for Metabolic Health. Central Asian Journal of Medical and Natural Science. 2023 . 16;4(5):632-9.

35- Rossignol P, Williams B, Mayo MR et al. Patiromer versus placebo to enable spironolactone use in patients with resistant hypertension and chronic kidney disease (AMBER): results in the pre-specified subgroup with heart failure. Eur J Heart Fail. 2022. 22(8):1462–1471.

36- Butler J, Anker SD, Lund LH, Coats AJS, Filippatos G, Siddiqi TJ, Friede T, Fabien V, Kosiborod M, Metra M, Piña IL, Pinto F, Rossignol P, van der Meer P, Bahit C, Belohlavek J, Böhm M, Brugts JJ, Cleland JGF, Ezekowitz J, Bayes-Genis A, Gotsman I, Goudev A, Khintibidze I, Lindenfeld J, Mentz RJ, Merkely B, Montes EC, Mullens W, Nicolau JC, Parkhomenko A, Ponikowski P, Seferovic PM, Senni M, Shlyakhto E, Cohen-Solal A, Szecsödy P, Jensen K, Dorigotti F, Weir MR, Pitt B. Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial. Eur Heart J. 2022 Nov 1;43(41):4362-4373.

37- Tardif JC, Rouleau J, Chertow GM, Al-Shurbaji A, Lisovskaja V, Gustavson S, Zhao Y, Bouabdallaoui N, Desai AS, Chernyavskiy A, Evsina M, Merkely B, McMurray JJV, Pfeffer MA. Potassium reduction with sodium zirconium cyclosilicate in patients with heart failure. ESC Heart Fail. 2023 . 10(2):1066-1076.

38- Li L, Harrison SD, Cope MJ et al. Mechanism of action and pharmacology of patiromer, a nonabsorbed cross-linked polymer that lowers serum potassium concentration in patients with hyperkalemia. J Cardiovasc Pharmacol Ther.2016. 21(5):456–465.

39- Murphy D, Banerjee D. Hyperkalaemia in heart failure: consequences for outcome and sequencing of therapy. Curr Heart Fail Rep.2022. 19(4):191.

40- Czerwinski F. Magnesium research in Canada: Highlights of the last two decades. Journal of Magnesium and Alloys. 2023. 11(10). 3399-3426.

41- Li YQ, Li F, Kang FW, Du HQ, Chen ZY. Recent research and advances in extrusion forming of magnesium alloys: A review. Journal of Alloys and Compounds. 2023 Aug 25;953:170080.

42- Oost, Lynette J., Cees J. Tack, and Jeroen HF de Baaij. "Hypomagnesemia and cardiovascular risk in type 2 diabetes." Endocrine Reviews (2023): 44(3); 357-378.

43- Dziubinska A, Siemionek E, Surdacki P, Kulisz M, Koczurkiewicz B. Review of magnesium wheel types and methods of their manufacture. Materials. 2024 Jan 25;17(3):584.

44- Tahir NT, Falih IQ, AL_Husaini FK, Zeghair SA. Study the effect of chemerin level in type ii diabetic patients with and without retinopathy. Syst Rev Pharm. 2020 .11(1):1-6.

45- Schulze MB, Schulz M, Heidemann C, Schienkiewitz A, Hoffmann K, Boeing H. Fiber and magnesium intake and incidence of type 2 diabetes: a prospective study and meta-analysis. Archives of internal medicine. 2007 May 14;167(9):956-65.

46- Kao WL, Folsom AR, Nieto FJ, Mo JP, Watson RL, Brancati FL. Serum and dietary magnesium and the risk for type 2 diabetes mellitus: the Atherosclerosis Risk in Communities Study. Archives of internal medicine. 1999 Oct 11;159(18):2151-9.

47- Kurstjens, S., de Baaij, J. H., Bouras, H., Bindels, R. J., Tack, C. J., & Hoenderop, J. G. (2017). Determinants of hypomagnesemia in patients with type 2 diabetes mellitus. European journal of endocrinology, 176(1), 11-19.

48- Ghaedi, K., Ghasempour, D., Jowshan, M., Zheng, M., Ghobadi, S. and Jafari, A. Effect of zinc supplementation in the management of type 2 diabetes: A grading of recommendations assessment, development, and evaluation-assessed, dose-response meta-analysis of randomized controlled trials. Critical Reviews in Food Science and Nutrition, 2024. 64(25), pp.9228-9239.

49- ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, Collins BS, Gaglia JL, Hilliard ME, Isaacs D, Johnson EL. 2. Classification and diagnosis of diabetes: standards of care in diabetes—2023. Diabetes care. 2023 Jan 1;46(Supplement_1):S19-40.

50- Harzallah, A. , Kaaroud, H. , Hajji, M. , Hamida, F. , Khiari, K. , Gorsane, I. and Abdallah, T. (2016) Drug-Induced Acute Kidney Injury in Diabetes Mellitus. Open Journal of Nephrology, 6, 176-187. doi: 10.4236/ojneph.2016.64023.

51- Dominguez LJ, Veronese N, Marrone E, Di Palermo C, Iommi C, Ruggirello R, Caffarelli C, Gonnelli S, Barbagallo M. Vitamin D and Risk of Incident Type 2 Diabetes in Older Adults: An Updated Systematic Review and Meta-Analysis. Nutrients. 2024 . 22;16(11):1561.

52- Malinowska J, Małecka-Giełdowska M, Szymura W, Ciepiela O. Disturbances of calcium, magnesium, and phosphate homeostasis: incidence, probable causes, and outcome. Clinical Chemistry and Laboratory Medicine (CCLM). 2024. 20;62(11):e233-e235.

53- Shaker, Joseph L., and Leonard Deftos. "Calcium and phosphate homeostasis." Endotext [Internet] (2023).

54- Lin C, Chen CC, Chau T, Lin CS, Tsai SH, Lee DJ, Lee CC, Shang HS, Lin SH. Artificial intelligence-enabled electrocardiography identifies severe dyscalcemias and has prognostic value. Clinica Chimica Acta. 2022 Nov 1;536:126-34.

55- Thongprayoon C, Hansrivijit P, Petnak T, Mao MA, Bathini T, Vallabhajosyula S, Lertjitbanjong P, Qureshi F, Erickson SB, Cheungpasitporn W. Hospital-acquired serum ionized calcium derangements and their associations with in-hospital mortality. Medicines. 2020 Nov 19;7(11):70.

56- Li J, Wu N, Li Y, Ye K, He M, Hu R. Cross-sectional analysis of serum calcium levels for associations with left ventricular hypertrophy in normocalcemia individuals with type 2 diabetes. Cardiovascular diabetology. 2015 Dec;14:1-1.

57- Ichai C. Phosphate and Calcium Disorders. Metabolic Disorders and Critically Ill Patients: From Pathophysiology to Treatment. 2018:101-44.

58- Song HJ, Chia AZ, Tan BK, Teo CB, Lim V, Chua HR, Samuel M, Kee A. Electrolyte imbalances as poor prognostic markers in COVID-19: a systemic review and meta-analysis. Journal of endocrinological investigation. 2023 Feb;46(2):235-59.

59- Thanapongsatorn P, Sinjira T, Kaewdoungtien P, Kusirisin P, Kulvichit W, Sirivongrangson P, Peerapornratana S, Lumlertgul N, Srisawat N. Standard versus no post-filter ionized calcium monitoring in regional citrate anticoagulation for continuous renal replacement therapy (NPC trial). Clinical Kidney Journal. 2023 Sep;16(9):1469-79.

60- Cardinale A, Pambrun E, Prelipcean C, Messikh Z, Moranne O. Feasibility, Efficacy, and Safety of Peripheral Venous Access for Chronic Double-Filtration Plasmapheresis with Regional Citrate Anticoagulation. Blood Purification. 2023 Aug 1;52.

61- Aouchiche K, Reynaud R, Amodru V, Brue T, Cuny T. Teriparatide administration by the Omnipod pump: preliminary experience from two cases with refractory hypoparathyroidism. Endocrine. 2022 Jan 4:1-0.

62- Qazi AF, ur Rahman N, Mushtaq S, Anis R, Mahmud M, Pervaiz M. Metabolic Disruptions in Serum Calcium and Phosphate Levels Among Pre-Diabetic and Type 2 Diabetic Patients: Serum Calcium and Phosphate Levels in Diabetes Mellitus. Pakistan Journal of Health Sciences. 2024 31:191-5.

63- Tahir NT, Ahmed HS, Mohsen FY. Vitamin d and risk of osteoarthritis among Iraqi patients with and without metabolic syndrome. Plant Archives. 2020: 1;20(2).0972521.

64- Pethő ÁG, Tapolyai M, Browne M, Fülöp T. Hypomagnesemia as a risk factor and accelerator for vascular aging in diabetes mellitus and chronic kidney disease. Metabolites. 2023 19;13(2):306.

65- Qazi AF, ur Rahman N, Mushtaq S, Anis R, Mahmud M, Pervaiz M. Metabolic Disruptions in Serum Calcium and Phosphate Levels Among Pre-Diabetic and Type 2 Diabetic Patients: Serum Calcium and Phosphate Levels in Diabetes Mellitus. Pakistan Journal of Health Sciences. 2024 Jul 31:191-5.

66- Mohammed RB, Mohammed MM, Naeemah SJ. Clinical Evaluation of Niacin in Hemodialysis Patients with Hyperphosphatemia as Adjuvant to Calcium Carbonate. Al Mustansiriyah Journal of Pharmaceutical Sciences. 2020 1;20(3):82-93.

67- Daminov AT, Xurramova S, Islomov A, Ulashev M, Ikramov R, Mirzakhakimov P. Type 2 diabetes and bone mineral density in postmenopausal women. Science and Education. 2023;4(11):19-27.

68- Ismoilov JA, kizi Egamberdiyeva YK, Mahmamuradova NN, Daminov AT. Features of Vitamin-D Metabolism in Patients with Diabetic Nephropathy. Educational Research in Universal Sciences. 2024 Feb 12;3(4 SPECIAL):681-9.

69- Huang HY, Lin TW, Hong ZX, Lim LM. Vitamin D and diabetic kidney disease. International Journal of Molecular Sciences. 2023 Feb 13;24(4):3751.

70- Hussein Challoob M, Mohammed M T. Evaluation of Some Trace Elements and Serum Electrolytes in Patients with Acute Myocardial Infraction. Egyptian Journal of Chemistry,2023; 66(5), 93-97.‏

71- Laflamme D, Backus R, Brown S, Butterwick R, Czarnecki‐Maulden G, Elliott J, Fascetti A, Polzin D. A review of phosphorus homeostasis and the impact of different types and amounts of dietary phosphate on metabolism and renal health in cats. Journal of veterinary internal medicine. 2020 Nov;34(6):2187-96.

72- Wang AY, Kistler BM, Lambert K, Sumida K, Moore LW, Kalantar-Zadeh K. Nutrition and Metabolism for kidney health and disease management: 45 years of development and future directions under the International Society of renal nutrition and metabolism. Journal of Renal Nutrition. 2023 Nov 1;33(6):S1-5.

Downloads

Published

2026-01-07

How to Cite

The Crucial Role of Electrolytes in Diabetic Patients: article Review. (2026). Al Mustansiriyah Journal of Pharmaceutical Sciences, 25(5), 768-780. https://doi.org/10.32947/ajps.v25i5.1298

Similar Articles

41-50 of 92

You may also start an advanced similarity search for this article.